Unmet challenges in systemic therapy for early stage breast cancer
Despite marked progress in outcomes for women with early stage breast cancer, unmet challenges persist. These include accounting for the cohort of tumors that do not have favorable clinical outcomes related to tumor heterogeneity, particularly the variation within the subset of ER positive breast ca...
Main Author: | Harold J. Burstein |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-03-01
|
Series: | Breast |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0960977621010158 |
Similar Items
-
Advances in the Management of Early-Stage Triple-Negative Breast Cancer
by: Prarthna V. Bhardwaj, et al.
Published: (2023-08-01) -
Targeted Treatment for High-Risk Early-Stage Triple-Negative Breast Cancer: Spotlight on Pembrolizumab
by: Bagegni NA, et al.
Published: (2022-04-01) -
Salivary Glycopatterns as Potential Biomarkers for Screening of Early-Stage Breast Cancer
by: Xiawei Liu, et al.
Published: (2018-02-01) -
Retrospective Observational Study to Determine the Epidemiology and Treatment Patterns of Patients with Triple-Negative Breast Cancer
by: Magdalena Rosińska, et al.
Published: (2024-03-01) -
Staging Investigations in Asymptomatic Early Breast Cancer Patients at the Cancer Centre of Southeastern Ontario
by: Dalia Kamel, et al.
Published: (2021-06-01)